证券之星消息，11月20日南向资金增持203.9万股海吉亚医疗（06078.HK）。近5个交易日中，获南向资 金增持的有4天，累计净增持525.28万股。近20个交易日中，获南向资金增持的有15天，累计净增持 1214.38万股。截至目前，南向资金持有海吉亚医疗（06078.HK）2.1亿股，占公司已发行普通股的 34.01%。 海吉亚医疗控股有限公司是一家主要提供医疗服务的投资控股公司。该公司通过两个业务部门开展业 务。医院业务分部从事提供肿瘤一站式综合诊疗服务，围绕肿瘤核心业务开展多学科医疗服务，包括提 供医疗放疗、化疗、手术、靶向在内的多重肿瘤医疗服务，逐步覆盖癌症诊断、治疗与康复等各阶段。 其它业务分部主要从事其他业务。该公司主要在国内市场经营其业务。 以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 | 交易日 | 持股总数 (股) | 持股变动(股) | 变动幅度 | | --- | --- | --- | --- | | 2025-11-20 | 2.10亿 | 203.90万 | 0.98% | | 2025-11-1 ...

Group 1 - Southbound funds increased their holdings in Hai Ji Ya Medical (06078.HK) by 520,800 shares on November 6, 2025, marking a 0.26% change [1][2] - Over the past five trading days, southbound funds have increased their holdings on four occasions, with a total net increase of 3,135,000 shares [1][2] - In the last 20 trading days, there have been 14 days of net increases, totaling 6,655,400 shares [1][2] Group 2 - As of now, southbound funds hold 203 million shares of Hai Ji Ya Medical, representing 32.85% of the company's total issued ordinary shares [1][2] - Hai Ji Ya Medical Holdings Limited primarily engages in medical services, focusing on a comprehensive one-stop diagnosis and treatment service for cancer [2] - The company operates two segments: the hospital business, which provides multidisciplinary medical services centered around oncology, and other business segments [2]

Group 1 - The core point of the article is that southbound funds have reduced their holdings in Haijia Medical (06078.HK) by 140,200 shares on November 5, 2025, while there have been net increases in holdings on three days over the past five trading days, totaling 2,385,600 shares [1] - Over the last 20 trading days, southbound funds have increased their holdings in Haijia Medical on 14 days, with a total net increase of 7,178,000 shares [1] - As of now, southbound funds hold 203 million shares of Haijia Medical, accounting for 32.76% of the company's total issued ordinary shares [1] Group 2 - On November 5, 2025, the total number of shares held was 203 million, with a decrease of 140,200 shares, reflecting a change of -0.07% [2] - On November 4, 2025, there was an increase of 315,600 shares, representing a change of 0.16% [2] - On November 3, 2025, the increase was 1,771,000 shares, showing a change of 0.88% [2] - Haijia Medical Holdings Limited primarily engages in medical services, focusing on a comprehensive diagnosis and treatment service for tumors, covering multiple stages of cancer diagnosis, treatment, and rehabilitation [2]

Group 1 - Southbound funds increased their holdings in Hai Ji Ya Medical (06078.HK) by 338,200 shares on October 22, 2025 [1] - Over the past five trading days, there were four days of net increases in holdings, totaling 1,095,800 shares [1] - In the last 20 trading days, there were 15 days of net increases, accumulating to 10,469,800 shares [1] Group 2 - As of now, southbound funds hold 198 million shares of Hai Ji Ya Medical, accounting for 32.04% of the company's issued ordinary shares [1] - The company primarily operates in the medical services sector, focusing on comprehensive cancer diagnosis and treatment services [2] - Hai Ji Ya Medical's hospital business segment provides multidisciplinary medical services, including radiotherapy, chemotherapy, surgery, and targeted therapy [2]

Core Insights - Southbound funds increased their holdings in Hai Ji Ya Medical (06078.HK) by 36,000 shares on October 17, 2025, marking a positive trend in investment interest [1] - Over the past five trading days, there were four days of net increases in holdings, totaling 1,354,400 shares [1] - In the last 20 trading days, there were 15 days of net increases, accumulating to 10,684,200 shares [1] - As of now, southbound funds hold 198 million shares of Hai Ji Ya Medical, representing 31.94% of the company's total issued ordinary shares [1] Trading Data Summary - On October 17, 2025, total shares held were 198 million, with a change of 36,000 shares, reflecting a 0.02% increase [2] - On October 16, 2025, total shares held were 198 million, with a change of 455,800 shares, reflecting a 0.23% increase [2] - On October 15, 2025, total shares held were 197 million, with a change of 2,043,200 shares, reflecting a 1.05% increase [2] - On October 14, 2025, total shares held were 195 million, with a change of 441,800 shares, reflecting a 0.23% increase [2] - On October 13, 2025, total shares held were 195 million, with a change of -1,622,400 shares, reflecting a -0.83% decrease [2] Company Overview - Hai Ji Ya Medical Holdings Limited primarily engages in medical services, focusing on a two-segment operation [2] - The hospital business segment provides comprehensive diagnosis and treatment services for cancer, including multiple disciplines such as radiotherapy, chemotherapy, surgery, and targeted therapy [2] - The company gradually covers all stages of cancer diagnosis, treatment, and rehabilitation [2] - The company mainly operates its business in the domestic market [2]

Core Insights - Southbound funds increased their holdings in Hai Ji Ya Medical (06078.HK) by 2.0432 million shares on October 15, 2025, marking a 1.05% increase in total holdings [1] - Over the past 5 trading days, there were 3 days of net increases, totaling 541,600 shares [1] - In the last 20 trading days, there were 14 days of net increases, amounting to 11.0462 million shares [1] - As of now, southbound funds hold 197 million shares of Hai Ji Ya Medical, representing 31.86% of the company's total issued ordinary shares [1] Company Overview - Hai Ji Ya Medical Holdings Limited primarily engages in medical services, focusing on a comprehensive one-stop diagnosis and treatment service for cancer [2] - The company operates two segments: the hospital business segment, which provides multidisciplinary medical services centered around oncology, including radiotherapy, chemotherapy, surgery, and targeted therapies [2] - The company gradually covers all stages of cancer diagnosis, treatment, and rehabilitation [2] - Hai Ji Ya Medical mainly conducts its business in the domestic market [2]

Group 1 - The core point of the article highlights the recent trading activity of southbound funds in Hai Ji Ya Medical, indicating a net increase of 44.18 thousand shares on October 14, 2025, while experiencing a total net reduction of 45.82 thousand shares over the past five trading days [1][2] - Over the last 20 trading days, southbound funds have increased their holdings in Hai Ji Ya Medical for 13 days, resulting in a cumulative net increase of 8.8694 million shares [1][2] - As of now, southbound funds hold a total of 195 million shares of Hai Ji Ya Medical, which accounts for 31.54% of the company's total issued ordinary shares [1][2] Group 2 - Hai Ji Ya Medical Holdings Limited primarily engages in the provision of medical services, focusing on a two-segment operation model [2] - The hospital business segment offers comprehensive diagnosis and treatment services for cancer, including multiple disciplines such as radiotherapy, chemotherapy, surgery, and targeted therapy, covering all stages of cancer diagnosis, treatment, and rehabilitation [2] - The company mainly operates its business in the domestic market [2]

Company Overview - The company primarily engages in medical services, operating two segments: hospital services and other business segments, focusing on comprehensive cancer diagnosis and treatment services [10] Financial Performance - The company's revenue and net profit growth rates have shown fluctuations over the years, with a notable increase in revenue in 2021 and a decline in 2022 [12] - For the first half of 2025, the company reported a revenue of 23.81 billion, with a year-on-year growth rate of 9.06% [12] - The average return on equity for the first half of 2025 was 3.68%, a decrease of 2.28 percentage points compared to the same period last year [20] Revenue Composition - In the first half of 2025, the revenue composition included significant contributions from inpatient services and outpatient services [13] Asset and Liability Changes - As of the first half of 2025, the company's cash and cash equivalents increased by 70.63%, while trading financial assets decreased by 76.8% [26] - Long-term borrowings decreased by 10.26%, while short-term borrowings increased by 16.63% [29] Financial Ratios - The company's current ratio was 0.96, and the quick ratio was 0.86 as of the first half of 2025 [33] - The asset-liability ratio has shown a decreasing trend, with the latest figure at 33.04% [31]